GeneDx advocates for expanded genomic testing coverage
The company lobbied for the GACHA bill, shared SAVES Kids study results, and discussed AI at a health policy salon.
See the latest news and media coverage for GeneDx. We track all announcements, press releases, and industry mentions in real time, all in one place.
Genetic testing and genomic sequencing company
genedx.comLast updated
In short: GeneDx expanded insurance coverage and genomic testing access while reporting revenue growth and facing a series of shareholder lawsuits.
The company lobbied for the GACHA bill, shared SAVES Kids study results, and discussed AI at a health policy salon.
He joins from Quest Diagnostics to lead commercial and operations teams, focusing on execution and efficient scaling.
Revenue reached $102.3 million with 27% exome and genome revenue growth. Full-year guidance revised to $475-490 million.
The SAVES-Kids study found up to 61% reduction in healthcare costs for children with neurodevelopmental disorders after testing.
LOS ANGELES, July 7, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against GeneDx Holdings Corp. ("GeneDx" or "the...
Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired GeneDx Holdings Corp. (NASDAQ: WGS...
GeneDx Holdings Corp. advanced stock charts by Barron's. View WGS historical stock data and compare to other stocks, and exchanges.
GeneDx Holdings ( (WGS)) has shared an update. On February 27, 2026, GeneDx Holdings Corp. entered into a new $100 million term loan agreement with...
Track GeneDx and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to GeneDx and other trending companies.